[Federal Register Volume 64, Number 104 (Tuesday, June 1, 1999)]
[Notices]
[Pages 29328-29329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-13751]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Genetics of Drug Abuse Vulnerability.
    Date: June 1-2, 1999.
    Time: 9:00 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Rita Liu, PHD, Health Scientist Administrator, 
Office of Extramural Program Review, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-
2620.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, National Drug Abuse Treatment Clinical Trials 
Network.
    Date: June 22-23, 1999.
    Time: 9:00 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Omni Shoreham Hotel, 2500 Calvert Street, NW., 
Washington, DC 20008.
    Contact Person: Susan L. Coyle, PHD, Chief, Clinical 
Epidemiological and Applied Sciences Review Branch, Office of 
Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Program Projects Review Committee.
    Date: June 29, 1999.
    Time: 8:30 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Contact Person: Rita Liu, PHD, Health Scientist Administrator, 
Office of Extramural Program Review, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-
2620.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group Treatment Research Subcommittee.
    Date: June 29-30, 1999.
    Time: 9:00 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Kesinee Nimit, MD, Health Scientist 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 
Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, 
(301) 435-1432.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Centers Review Committee.
    Date: June 30, 1999.
    Time: 8:30 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Contact Person: Rita Liu, PHD, Health Scientist Administrator, 
Office of Extramural Program Review, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-
2620.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group Training and Career Development Subcommittee.
    Date: July 7-9, 1999.
    Time: 9:00 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda One, Bethesda Metro Center 
Bethesda, MD 20814.
    Contact Person: Mark Swieter, PHD, Health Scientist 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 
Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547 
(301) 435-1389.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group Health Services Research Subcommittee.

[[Page 29329]]

    Date: July 14, 1999.
    Time: 9:00 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Omni Shoreham Hotel, 2500 Calvert Street, NW, Washington, 
DC 20008.
    Contact Person: Marina L. Volkov, PHD, Special Assistant, Office 
of Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547 (301) 435-1433.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Research on Drug Courts.
    Date: July 19-20, 1999.
    Time: 9:00 AM to 5:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda, 
MD 20814.
    Contact Person: Marina L. Volkov, PHD, Special Assistant, Office 
of Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1433.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: May 23, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-13751 Filed 5-28-99; 8:45 am]
BILLING CODE 4140-01-M